Monimus Capital Management, LP Bridge Bio Pharma, Inc. Transaction History
Monimus Capital Management, LP
- $106 Billion
- Q4 2024
A detailed history of Monimus Capital Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Monimus Capital Management, LP holds 41,077 shares of BBIO stock, worth $1.3 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
41,077Holding current value
$1.3 Million% of portfolio
1.06%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
171MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$802 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$798 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$395 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$193 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.71B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...